Search by Drug Name or NDC

    NDC 42291-0494-30 Mirtazapine 7.5 mg/1 Details

    Mirtazapine 7.5 mg/1

    Mirtazapine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is MIRTAZAPINE.

    Product Information

    NDC 42291-0494
    Product ID 42291-494_0e90167d-1655-f3d6-e063-6394a90a17b0
    Associated GPIs
    GCN Sequence Number 054009
    GCN Sequence Number Description mirtazapine TABLET 7.5 MG ORAL
    HIC3 H7B
    HIC3 Description ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS
    GCN 21817
    HICL Sequence Number 011505
    HICL Sequence Number Description MIRTAZAPINE
    Brand/Generic Generic
    Proprietary Name Mirtazapine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Mirtazapine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 7.5
    Active Ingredient Units mg/1
    Substance Name MIRTAZAPINE
    Labeler Name AvKARE
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076541
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0494-30 (42291049430)

    NDC Package Code 42291-494-30
    Billing NDC 42291049430
    Package 30 TABLET in 1 BOTTLE (42291-494-30)
    Marketing Start Date 2022-08-02
    NDC Exclude Flag N
    Pricing Information N/A